Patient Outcomes

Repeat colonoscopies not always beneficial for some patients

Repeat colonoscopies not always beneficial for some patients

Little benefit seen for repeat colonoscopy within 10 years in patients with no polyps on initial exam.

Research team makes cancer glow to improve surgical outcomes

Research team makes cancer glow to improve surgical outcomes

Surgical resection is the most effective method for a cancer cure; however, the procedure may not remove the entire tumor, leading to local recurrence. Researchers at the University of Pennsylvania have established a new strategy in which near-infrared (NIR) imaging is used to help visualize the entire tumor.

Survival equivalent with cetuximab or bevacizumab in metastatic colorectal cancer

By

For patients with KRAS wild-type untreated colorectal cancer, adding cetuximab or bevacizumab to combination chemotherapy offers equivalent survival.

Study compares treatment risks for early esophageal cancer

Study compares treatment risks for early esophageal cancer

A new study sheds new light on the risks associated with the growing popularity of endoscopic resection in the treatment of localized, early-stage esophageal cancer.

Everolimus does not improve overall survival of advanced liver cancer

By

Despite strong preclinical data, the drug everolimus failed to improve overall survival in patients with advanced liver cancer, compared to placebo, according to a study.

A review of radiotherapy-induced hypopituitarism

A review of radiotherapy-induced hypopituitarism

By

Some patients undergoing radiotherapy for cancers of the head, neck, and brain are at risk for endocrinopathies. This article reviews the risks, detection, and management of radiotherapy-induced hypopituitarism.

Lifestyle choices may lower metabolic syndrome risk of for cancer survivors

Lifestyle choices may lower metabolic syndrome risk of for cancer survivors

A study conducted by researchers based at the St. Jude Children's Research Hospital has determined that healthy lifestyle choices can help cancer survivors avoid the metabolic syndrome.

Lack of Trust in One's Doctor Affects Health of Emotionally Vulnerable Cancer Patients

Lack of Trust in One's Doctor Affects Health of Emotionally Vulnerable Cancer Patients

Patients' relationship with their doctor and their attachment style may affect their physical and mental well-being, especially during vulnerable times such after a cancer diagnosis, according to a new study.

Exercise And Nutrition Counseling Plus Palliative Care Improves Quality Of Life For Patients With Cancer

Exercise And Nutrition Counseling Plus Palliative Care Improves Quality Of Life For Patients With Cancer

A team of researchers in Canada concludes that combining exercise, nutritional counseling, and symptom control to palliative care from diagnosis helps to improve the quality of life for patients with cancer.

Noninvasive advanced image analysis may improve care for lung cancer patients

By

Lung cancer patients could receive more precise treatment, and their progress could be better tracked by using a new high-tech method of non-invasive medical imaging analysis, according to a new study.

Rates of observation as prostate cancer management vary

Rates of observation as prostate cancer management vary

Rates of observation as management for low-risk prostate cancer vary widely, and primary ADT is not tied to better survival for men with localized prostate cancer.

Managing follicular lymphoma

Managing follicular lymphoma

Changes in how follicular lymphoma is managed have led to substantial improvement in prognosis and over all survival for patients with the disease.

New drug active against most aggressive type of lung cancer

By

Scientists have shown that a new drug could prove useful in treating small cell lung cancer, the most aggressive form of lung cancer.

Depressed men with prostate cancer have worse outcomes

Depressed men with prostate cancer have worse outcomes

Depressed men with a diagnosis of intermediate- or high-risk prostate cancer have worse overall outcomes.

Doctors steer prostate cancer treatment choices

Doctors steer prostate cancer treatment choices

Physicians who diagnosed low-risk prostate cancer had more influence over the decision to enter active surveillance than did the disease characteristics, according to a case review.

Radiation-induced toxicity risk in prostate cancer predicted by variations in key gene

By

Key genetic variants may affect how cancer patients respond to radiation treatments, according to a new study.

DII may be a potential determinant of hospitalization duration among surgically treated patients with colorectal cancer

DII may be a potential determinant of hospitalization duration among surgically treated patients with colorectal cancer

The dietary inflammatory index may be used as a potential predictor of length of hospitalization among patients undergoing surgical treatment of colorectal cancer, according to a team of researchers at Jagiellonian University Medical College, in Krakow, Poland.

Nanoliposome formulation improves drug delivery and survival in metastatic pancreatic cancer

By

The addition of MM-398, a novel nanoliposome formulation of irinotecan, to standard treatment improves survival for metastatic pancreatic cancer patients who have already received gemcitabine.

Insurer's study finds cost-effective way to treat cancer

Insurer's study finds cost-effective way to treat cancer

A new model for paying oncologists reduced cancer care costs by 34% without changing how well patients fared after treatment, according to a study conducted by UnitedHealthcare.

Telephone call is effective support when breast cancer treatment includes weight loss

By

A series of simple telephone calls can make a profound difference in helping women with breast cancer to meet their treatment goals for weight loss.

Combination treatment improves recurrence and survival in ovarian cancer

By

A new combination of medications for treatment of recurrent ovarian cancer showed improved response rates, increased the rate of tumor shrinkage, and prolonged the time until cancers recurred

Benefits of trastuzumab outweigh the risk of harm in advanced breast cancer

By

A new systematic review shows that treatment with the breast cancer drug trastuzumab is associated with prolonged survival in women with advanced breast cancer, but the risk of developing heart problems also increases.

Study Results Demonstrate A New Prostate Cancer Treatment

Study Results Demonstrate A New Prostate Cancer Treatment

A new study is suggesting a different approach to treating prostate cancer. Researchers at Comprehensive Cancer Centers of Nevada conducted a study in which 790 men with advanced stages of prostate cancer received early chemotherapy.

Bisphenol A Triggers Changes in Rats That May Lead to Breast Cancer

Bisphenol A Triggers Changes in Rats That May Lead to Breast Cancer

New research presents another cause for concern in regard to the chemical bisphenol A (BPA). The study is the first to examine what impact BPA has on the DNA of mammary glands as they age.

Risk of hospitalization increased for childhood cancer survivors, even years after treatment

By

Survivors of childhood cancers were hospitalized more often and had longer hospital admissions many years after cancer treatment was completed, compared with the general population.

Early initiation of palliative care support improves caregiver quality of life and patient survival

Early initiation of palliative care support improves caregiver quality of life and patient survival

The earlier a specific phone-based, palliative care support program can be introduced to caregivers, the better they will be able to cope with the caregiving experience, according to research conducted by University of Alabama at Birmingham School of Nursing investigators.

Answering the unanswerable

Answering the unanswerable

By

Sometimes the best answer to a patient's question is quiet support. Can you recognize when no words are needed?

LDCT screening for lung cancer does not induce long-term anxiety or distress

By

A review of studies that evaluated patient-centered outcomes of LDCT screening for lung cancer found that overall quality of life is not significantly impacted in persons who undergo the screening procedure.

Study demonstrates improved diagnosis and outcomes with LDCT

By

A study using a 5-year LDCT screening protocol showed good adherence and patient survival outcomes in persons at high risk of developing lung cancer.

Molecular breast imaging protocol unmasks more cancer in advanced cases

By

Patients with advanced breast cancer that may have spread to their lymph nodes could benefit from a more robust dose of a molecular imaging agent when undergoing lymphoscintigraphy.

Sign Up for Free e-newsletters


What is this?

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs